- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04271358
Peer Coaching Intervention in Young Adults With Congenital Heart Disease (CHASM in ACHD)
June 1, 2026 updated by: Duke University
Peer Coaching Adaptive Self-Management Interventions for Young Adults With Congenital Heart Disease
The purpose of the study is to evaluate a peer coaching intervention in young adults with congenital heart disease.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Our research team has developed a peer coaching intervention that has been deployed to promote activated self-management for AYAs with several conditions, and this has been modified adolescents and young adults (AYA) with with congenital heart disease (CHD).
This study will be conducted over two years and pair AYA with CHD with a peer coach who also has CHD has successfully navigated the transition to adult medical care and over six months will work to promote the motivation for self-care as well as the development of self-management skills.
This pilot study will test feasibility and acceptability, as well as preliminary efficacy and long-term effects on successful transfer to adult cardiology.
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 26 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18-26
- Diagnosis of congenital heart disease
- Patient at a Duke pediatric cardiology clinic
- Access to a smart phone
Exclusion Criteria:
- Cognitive delay
- Patient at an adult cardiology clinic
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Peer Coaching
Participant receive a 6 month peer health coaching intervention.
|
The Peer Coaching group will receive 6 months of peer health coaching via a secure telephone and text messaging system.
|
|
No Intervention: Education only
Participants receive education-only material (newsletter) biweekly for 6 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate number of participants enrolled
Time Frame: Up to 2 months after recruitment closes
|
Evaluate the number of participants contacted about the study who actually enrolled
|
Up to 2 months after recruitment closes
|
|
Evaluate completion of study
Time Frame: Up to 8 months after enrollment of each participant
|
Determine the number of participants who enrolled in the study who completed it
|
Up to 8 months after enrollment of each participant
|
|
Measure impact on health
Time Frame: Up to 8 months after enrollment of each participant
|
Evaluate the number of participant who stated the intervention had a positive impact on their health
|
Up to 8 months after enrollment of each participant
|
|
Determine change in patient activation
Time Frame: baseline, 3 months, 6 months
|
Determine change in patient activation as measured by changes over time on the Patient Activation Measure (PAM)
|
baseline, 3 months, 6 months
|
|
Determine change in self-management
Time Frame: baseline, 3 months, 6 months
|
Determine change in self-management as measured by changes over time in the Partners in health Scale (PIH)
|
baseline, 3 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine change in transition readiness
Time Frame: baseline, 3 months, 6 months
|
Determine the change in transition readiness over 6 months as measured by the Transition Readiness Assessment Questionaire (TRAQ)
|
baseline, 3 months, 6 months
|
|
Determine change in health related quality of life
Time Frame: baseline, 3 months, 6 months
|
Determine the change in health related quality of life over 6 months as measured by the Short-From 12 (SF-12)
|
baseline, 3 months, 6 months
|
|
Determine change in emotional health
Time Frame: baseline, 3 months, 6 months
|
Determine the change in emotional health over 6 months as measured by the Brief Symptom Inventory (BSI)
|
baseline, 3 months, 6 months
|
|
Evaluate successful transfer of participants from pediatric to adult cardiology care
Time Frame: up to 10 years
|
Evaluate number of participants that transfer from pediatric to adult cardiology care with at least consecutive visits 10 years post study
|
up to 10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Richard A Krasuski, MD, Duke University
- Principal Investigator: Gary Maslow, MD, MPH, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 8, 2020
Primary Completion (Actual)
January 18, 2023
Study Completion (Estimated)
March 2, 2032
Study Registration Dates
First Submitted
February 13, 2020
First Submitted That Met QC Criteria
February 13, 2020
First Posted (Actual)
February 17, 2020
Study Record Updates
Last Update Posted (Actual)
June 2, 2026
Last Update Submitted That Met QC Criteria
June 1, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00103600
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingAdult Congenital Heart Disease | Congenital Heart Disease (CHD) | Pediatric Congenital Heart Disease | Heart Transplant PatientsItaly
-
Seoul National University HospitalUniversity of SeoulNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD) | Complex Congenital Heart DiseaseKorea, Republic of
-
University of UlsterBelfast Health and Social Care TrustCompletedCongenital Heart Disease | Congenital Heart Defect | Adult Congenital Heart DiseaseUnited Kingdom
-
China National Center for Cardiovascular DiseasesPeking University; Shandong University; Guangxi Medical University; Wenzhou Medical... and other collaboratorsActive, not recruitingStructural Heart Disease | Congenital Heart Disease (CHD)China
-
The Children's Hospital of Zhejiang University...Beijing Children's Hospital; Children's Hospital of Nanjing Medical UniversityNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD)China
-
Children's Hospital Medical Center, CincinnatiNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Disease CongenitalUnited States
-
Martin SchweigerUniversity Children's Hospital, ZurichRecruitingFontan Physiology | Congenital Heart Disease in Children | Congenital Heart SurgerySwitzerland
-
University Hospital, BordeauxNot yet recruitingCHD - Congenital Heart DiseaseFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingAdult Congenital Heart DiseaseItaly
-
University of CalgaryThe Hospital for Sick Children; Alberta Children's HospitalNot yet recruitingCongenital Heart Disease (CHD)
Clinical Trials on Peer Health Coaching
-
University of California, San FranciscoAmerican Academy of Family PhysiciansCompleted
-
Spaulding Rehabilitation HospitalDeborah Munroe Noonan Memorial Research FundActive, not recruitingCerebral Palsy | Spina BifidaUnited States
-
Slovak Academy of SciencesUniversity Hospital Bratislava Comenius University; Kempelen Institute of Inteligent...Recruiting
-
Women's College HospitalUniversity Health Network, Toronto; Canadian Cancer Society (CCS); Public Health... and other collaboratorsActive, not recruitingCancer | Chronic DiseaseCanada
-
Brittany L SmallsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingDiabetes Mellitus, Type 2United States
-
VA Office of Research and DevelopmentActive, not recruitingHousing | Acute Care Service Utilization | Mental Health Status | Physical Health StatusUnited States
-
Tufts Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Active, not recruitingFatigue | Systemic Lupus ErythematosusUnited States
-
Temple UniversityNational Institute on Disability, Independent Living, and Rehabilitation...CompletedSevere Mental DisorderUnited States
-
Medical College of WisconsinCompleted
-
Baystate Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); University of Michigan; University... and other collaboratorsRecruitingChronic Obstructive Pulmonary DiseaseUnited States